
A heart murmur is an abnormal, turbulent flow of blood that can be heard with a stethoscope when the heart beats. Murmurs are classified by timing (systolic, diastolic, or continuous), intensity (graded I–VI on the Levine scale), location, and quality (blowing, harsh, musical).
- Systolic murmurs occur during ventricular contraction.
- Diastolic murmurs arise when the ventricles relax and fill.
- Continuous murmurs persist through both phases and often signal a shunt or severe valvular disease.
A murmur alone is not a disease; it is a sign that something abnormal is happening within the cardiovascular system. Some murmurs are innocent (physiologic) and harmless, while others indicate structural heart disease that may progress to heart failure if untreated.
2. Underlying Causes of Murmurs in Dogs
| Category | Specific Etiologies | Pathophysiology |
|---|---|---|
| Congenital anomalies | – Patent ductus arteriosus (PDA) – Aortic or pulmonic stenosis – Subaortic membrane – Ventricular septal defect (VSD) – Atrioventricular (AV) canal defects |
Abnormal openings or narrowed outflow tracts produce high‑velocity flow across the defect, creating turbulence. |
| Acquired valvular disease | – Myxomatous mitral valve disease (MMVD) – Endocardial fibroelastosis – Aortic valve dysplasia – Tricuspid valve dysplasia |
Degeneration, thickening, or fibrosis of valve leaflets leads to regurgitation or stenosis, generating murmurs. |
| Cardiomyopathies | – Dilated cardiomyopathy (DCM) – Hypertrophic cardiomyopathy (HCM) (rare in dogs) |
Remodeling of myocardial tissue changes chamber dimensions and pressures, often producing a soft systolic murmur. |
| Systemic diseases | – Anemia (high-output states) – Hyperthyroidism – Fever, sepsis – Pregnancy |
Increased blood volume or velocity amplifies normal flow turbulence, creating a functional (innocent) murmur. |
| Infectious/inflammatory | – Bacterial endocarditis – Rheumatic fever (extremely rare) |
Vegetations or inflammation on valve surfaces disrupt laminar flow. |
| Neoplasia | – Cardiac hemangiosarcoma, lymphoma, or metastasis | Tumors can obstruct outflow tracts or cause valve dysfunction. |
| Iatrogenic/Traumatic | – Cardiac catheterization, blunt trauma, surgical complications | Direct damage to valve or myocardium creates abnormal flow. |
Key Takeaway: In most dogs, the most common cause of a clinically relevant murmur is myxomatous mitral valve disease (MMVD), especially in small‑breed, older dogs. However, younger dogs may present with congenital lesions that require early surgical correction.
3. Clinical Signs & Symptoms
The presence of a murmur does not guarantee overt clinical disease. However, when the underlying cardiac pathology progresses, typical signs may appear:
| System | Signs | Comments |
|---|---|---|
| Respiratory | Cough (dry, especially at night) Exercise intolerance Rapid, shallow breathing (tachypnea) Labored breathing (dyspnea) Orthopnea (relief when lying on side) |
Pulmonary edema from left‑sided heart failure is a hallmark of advanced MMVD. |
| Cardiovascular | Weak or irregular pulse Bounding pulses (in cases of PDA) Jugular venous distension (right‑sided failure) |
Palpable thrills may be felt over the murmur area. |
| General | Lethargy, decreased appetite, weight loss Ascites (abdominal fluid) Syncope or collapse (rare, often with severe stenosis) |
Systemic signs indicate that cardiac output is insufficient to meet metabolic demands. |
| Neurologic | Episodes of fainting may arise from transient cerebral hypoperfusion in severe outflow obstruction. | |
| Other | Exercise‑induced fatigue, inability to climb stairs or jump onto furniture. |
Note: Innocent murmurs in young, healthy puppies are typically soft (grade I–II) and do not accompany any of the above signs.
4. Dog Breeds Most Prone to Heart Murmurs
| Breed | Predominant Lesion(s) | Why This Breed Is At Risk |
|---|---|---|
| Cavalier King Charles Spaniel | Myxomatous mitral valve disease (MMVD) | Genetic predisposition; small thoracic cavity → higher valve stress. |
| Maltese | MMVD | Similar to other toy breeds; early onset (as young as 3–4 years). |
| Pomeranian | MMVD, subaortic stenosis (rare) | Small breed, high metabolic rate, rapid valve degeneration. |
| Chihuahua | MMVD, PDA (congenital) | Small size leads to relatively higher blood flow velocities; PDA incidence ≈ 1% of litters. |
| Miniature Schnauzer | MMVD, DCM (rare) | Genetic background for valve degeneration and occasional cardiomyopathy. |
| German Shepherd | Dilated cardiomyopathy (DCM) | Breed predisposition to hereditary DCM; often manifested as a soft systolic murmur. |
| Boxer | Aortic stenosis (congenital) | Familial inheritance; murmur often detected early. |
| Newfoundland | Subvalvular aortic stenosis, PDA | Large breed with reported congenital defects. |
| Doberman Pinscher | DCM, valvular dysplasia | Heritable DCM is a leading cause of premature death. |
| Golden Retriever | DCM (particularly in males) | Emerging breed‑specific DCM, especially in genetically vulnerable lines. |
Paragraph Explanation
Why Do Certain Breeds Carry Higher Murmur Risks?
The predilection of specific breeds for particular cardiac lesions stems from a combination of genetic inheritance, anatomical conformation, and physiological factors. In toy and small breeds such as the Cavalier King Charles Spaniel, the mitral valve leaflets are more susceptible to myxomatous degeneration due to a genetically programmed excess production of proteoglycans, leading to valve thickening and prolapse. Larger or working breeds like the German Shepherd and Doberman have been selectively bred for muscle mass and high metabolic output, which can unmask genetic mutations affecting the cardiac sarcomere proteins, resulting in dilated cardiomyopathy. Congenital defects, especially outflow tract obstructions like subaortic stenosis, are inherited as autosomal recessive or polygenic traits in breeds such as the Boxer and Newfoundlands. Knowledge of breed‑specific risks aids veterinarians in early screening, which dramatically improves outcomes for dogs with potentially progressive murmurs.
5. Age‑Related Occurrence
| Age Group | Typical Murmur Etiologies | Clinical Relevance |
|---|---|---|
| Puppy (≤ 6 months) | – Congenital PDA, VSD, aortic/pulmonic stenosis – Innocent (physiologic) murmurs from high cardiac output |
Early detection is vital; many congenital lesions are surgically correctable with a good prognosis if treated before irreversible pulmonary hypertension develops. |
| Young Adult (6 months – 3 years) | – Early onset MMVD in predisposed small breeds – Traumatic or iatrogenic murmurs (rare) |
Murmurs are often graded I‑II; regular re‑evaluation recommended to watch for progression. |
| Adult (3 – 7 years) | – Progressive MMVD (most common) – Early DCM in Dobermans, German Shepherds |
This is the critical window for initiating medical therapy in MMVD (e.g., pimobendan, ACE inhibitors). |
| Senior (> 7 years) | – Advanced MMVD with regurgitation and heart failure – Late‑onset DCM, valvular dysplasia – Functional murmurs secondary to systemic disease (anemia, hyperthyroidism) |
Prognosis varies; many dogs will develop clinical signs requiring chronic management, home monitoring, and quality‑of‑life decisions. |
Key Point: While congenital murmurs are most common in puppies, acquired valvular disease dominates in adult and senior dogs. Routine auscultation at annual wellness exams (earlier for at‑risk breeds) is the cornerstone of early detection.
6. Diagnostic Work‑up
- Comprehensive Physical Examination
- Standardized auscultation in a quiet environment.
- Grading and localization of the murmur.
- Palpation for thrills, pulse quality, and evidence of pleural/abdominal effusion.
- Thoracic Radiography
- CXR (2‑view: lateral & VD) to assess cardiac silhouette (vertebral heart score), pulmonary vasculature, and presence of pulmonary edema or pleural effusion.
- Helps differentiate left‑ vs. right‑sided heart disease.
- Echocardiography (Ultrasound) – Gold Standard
- Two‑dimensional imaging to visualize chamber size, wall thickness, valve morphology, and any congenital defects.
- Doppler studies (color, spectral) quantify regurgitant flow, pressure gradients (e.g., across stenotic valves), and estimate pulmonary artery pressure.
- M‑mode for precise measurements of mitral valve leaflet motion and left ventricular dimensions (LVIDd, LVIDs).
- Electrocardiography (ECG)
- Detects arrhythmias, chamber enlargement (e.g., P‑wave amplitude changes), and conduction abnormalities often associated with cardiomyopathy.
- Blood Work
- CBC & Chemistry: Rule out anemia, renal/hepatic disease, hyperthyroidism.
- NT‑proBNP or cardiac troponin I (cTnI): Biomarkers that rise with myocardial stretch or injury; useful for monitoring disease progression.
- Advanced Imaging (if needed)
- CT or MRI for complex congenital anomalies or vascular ring anomalies.
- 3‑D echocardiography for detailed valve anatomy in surgical planning.
- Genetic Testing (optional, breed‑specific)
- For DCM in Dobermans (e.g., PDK4, TTN mutations) or other breed‑linked cardiac genes.
Diagnostic Algorithm Overview
- Murmur detected → Auscultation grade & timing.
- If grade III–VI or accompanied by clinical signs → Immediate thoracic radiographs + ECG.
- If radiographs indicate cardiac enlargement or pulmonary edema → Full echocardiogram.
- If murmur is low‑grade in a young puppy with no signs → Re‑examine in 6‑8 weeks; consider screening echocardiogram if breed‑predisposed.
7. Therapeutic Strategies
7.1 Medical Management
| Condition | First‑Line Medications | Mechanism | Monitoring |
|---|---|---|---|
| Myxomatous Mitral Valve Disease (MMVD) | – Pimobendan (positive inotrope + vasodilator) – ACE inhibitors (e.g., enalapril, benazepril) – Furosemide (loop diuretic) – Spironolactone (potassium‑sparing) – Sodium nitroprusside (short‑acting vasodilator for acute decompensation) |
Improves contractility, reduces afterload, and controls congestion. | Re‑check echo every 3–6 months; watch for electrolyte disturbances. |
| Dilated Cardiomyopathy (DCM) | – Sodium Carboxymethylcellulose (Sodium D‑β‑hydroxybutyrate) for arrhythmia control – Sotalol or diltiazem for ventricular premature complexes – ACE inhibitors & pimobendan (if systolic dysfunction) |
Reduce arrhythmia burden and support weakened myocardium. | Serial echocardiography; Holter monitoring for arrhythmias. |
| Congenital Stenosis (Aortic/Pulmonic) | – Beta‑blockers (e.g., atenolol) to reduce heart rate & improve diastolic filling – Sildenafil for pulmonary hypertension secondary to left‑sided disease |
Lower myocardial oxygen consumption; treat secondary PH. | Blood pressure, echocardiographic pressure gradients. |
| Patent Ductus Arteriosus (PDA) | – Indomethacin or ibuprofen (NSAID closure) in neonates – Aspirin (rarely) for mild cases |
Inhibit prostaglandin synthesis → ductal closure. | Monitor renal function; ultrasound to confirm closure. |
| Endocarditis | – IV antibiotics (e.g., ampicillin + enrofloxacin) for ≥ 6 weeks – Anticoagulation (if vegetation > 1 cm) |
Eradicate bacterial infection; prevent emboli. | Blood cultures, echo for vegetative resolution. |
Adjunctive Therapies
- Omega‑3 fatty acids (EPA/DHA) – anti‑inflammatory; may reduce arrhythmias.
- Coenzyme Q10 – supports mitochondrial energy production, helpful in DCM.
- Bronchodilators (e.g., terbutaline) for severe cough due to airway irritation from pulmonary edema.
7.2 Surgical & Interventional Options
| Procedure | Indications | Success Rate | Post‑Operative Care |
|---|---|---|---|
| Percutaneous Occlusion of PDA (Amplatz or Coil) | Moderate‑to‑large PDA in puppies or small adults | > 95 % closure in experienced centers | Aspirin 5 mg/kg for 7 days; repeat echo at 1 month. |
| Balloon Valvuloplasty (Aortic or Pulmonic) | Severe subaortic or pulmonic stenosis (gradient > 50 mmHg) | 80‑90 % reduction of pressure gradient | Antiplatelet therapy (clopidogrel) 1 wk; echo at 3 months. |
| Mitral Valve Repair/Replacement (rare, experimental) | End‑stage MMVD unresponsive to medical therapy | Limited data; high morbidity | Lifelong anticoagulation if mechanical valve used. |
| Open‑Heart Surgical Correction of VSD | Large VSD causing CHF | 85‑90 % closure, but high cost | ICU monitoring, analgesia, antibiotics. |
7.3 Palliative & End‑of‑Life Care
When disease progresses despite optimal therapy, focus shifts to quality of life:
- Adjust diuretic dosing for comfort (avoid overt dehydration).
- Provide oxygen supplementation if severe dyspnea.
- Analgesics (e.g., buprenorphine) for cough‑related discomfort.
- Euthanasia discussions should be guided by owner wishes, functional status, and pain level.
8. Prognosis & Possible Complications
| Condition | Typical Prognosis (Untreated) | Prognosis With Treatment | Common Complications |
|---|---|---|---|
| Mild MMVD (grade I–II) | Excellent – may never progress to clinical disease. | Near‑normal lifespan; periodic re‑checks. | Occasional progression to higher grade. |
| Moderate MMVD (grade III–IV) | Progressive CHF within 1–3 years. | Median survival 2–5 years with pimobendan + ACEi. | Pulmonary edema, atrial fibrillation, thromboembolism. |
| Severe MMVD (grade V–VI) | Rapid decompensation, median survival < 12 months. | Extended survival to 1–2 years with aggressive therapy. | Refractory CHF, severe arrhythmias, hepatic congestion. |
| PDA (if untreated) | Development of Eisenmenger syndrome, severe PH, and death within 1–2 years. | > 95 % survival after successful occlusion. | Residual shunt, thromboembolic events. |
| Aortic Stenosis | Sudden death from arrhythmia or CHF; median survival 2–5 years. | Beta‑blocker therapy improves lifespan modestly. | Syncope, myocardial ischemia, sudden cardiac death. |
| Dilated Cardiomyopathy | Median survival 6‑12 months after onset of CHF. | Early detection + ACEi + pimobendan can extend to 18‑24 months. | Ventricular arrhythmias, thromboembolism, sudden death. |
| Infective Endocarditis | Fatal if not treated; 30‑day mortality > 40 %. | Aggressive IV antibiotics can salvage 50‑60 % of cases. | Embolic strokes, valvular destruction, heart block. |
Complication Highlights
- Arrhythmias: Atrial fibrillation is common in advanced MMVD; ventricular premature complexes dominate in DCM.
- Thromboembolism: Particularly in DCM (left atrial thrombus) and PDA with residual shunt.
- Pulmonary Hypertension (PH): May develop secondary to left‑sided disease, worsening dyspnea.
- Renal Insufficiency: Chronic diuretic use can precipitate azotemia; monitor creatinine and electrolytes.
9. Prevention & Early Detection
| Strategy | Details | Frequency |
|---|---|---|
| Breed‑Specific Screening | Early echocardiography for high‑risk breeds (Cavalier, Doberman) starting at 6‑12 months. | Annually for at‑risk breeds; every 2 years for average breeds. |
| Regular Wellness Exams | Auscultation, weight, blood pressure, and heart rate assessment. | At least once per year; semi‑annual for senior dogs. |
| Nutrition & Weight Management | Maintain ideal body condition score (BCS 4–5/9). Overweight dogs have increased cardiac workload. | Ongoing; evaluate BCS at each visit. |
| Exercise Regulation | Moderate, consistent activity; avoid extreme exertion in dogs with known murmurs. | Daily, tailored to individual health status. |
| Vaccination & Parasite Control | Prevent systemic infections that can exacerbate cardiac disease (e.g., heartworm). | Core vaccines per schedule; heartworm prophylaxis monthly. |
| Genetic Counseling | For breeders: genetic testing for DCM in Dobermans, MMVD susceptibility in Cavaliers. | Before breeding; keep health records. |
| Avoid Tobacco Smoke & Environmental Toxins | Second‑hand smoke and certain chemicals can worsen cardiovascular health. | Household-wide. |
Key Message: While many cardiac murmurs are genetically programmed, early detection coupled with lifestyle optimization can dramatically delay progression and improve quality of life.
10. Diet & Nutritional Support
- Low‑Sodium Diet
- Goal: < 0.2 % Na on a dry‑matter basis (≈ 140 mEq Na⁺/kg).
- Benefits: Reduces fluid retention, eases workload on the heart.
- High‑Quality Protein
- Essential amino acids to prevent muscle wasting (especially in CHF).
- Use digestible sources: poultry, fish, or novel proteins for renal‑compromised patients.
- Omega‑3 Fatty Acids (EPA/DHA)
- Dose: 100 mg EPA + DHA per kg body weight daily.
- Anti‑inflammatory, can improve ventricular function and reduce arrhythmia frequency.
- Taurine & L‑Carnitine
- Particularly useful in DCM‑prone breeds (e.g., Golden Retrievers, Boxers).
- Supplement at 250 mg taurine/kg and 50 mg L‑carnitine/kg daily, under veterinary guidance.
- Antioxidants (Vitamin E, Selenium, CoQ10)
- Counteract oxidative stress on myocardial cells.
- CoQ10: 2 mg/kg BID (twice daily).
- Caloric Management
- Cachexia risk in advanced CHF → increase caloric density with medium‑chain triglycerides (MCT) or commercial cardiac formulas.
- Obesity risk in earlier stages → controlled portion sizes, weight‑loss plans (5‑10 % reduction over 3–6 months).
- Hydration
- In early CHF, maintain moderate fluid intake; in overt fluid overload, restrict free water and monitor intake.
Feeding Recommendations
- Commercial Cardiac Diets (e.g., Hill’s Prescription Diet k/d, Royal Canin Cardiac) are formulated with the above principles and are convenient for most owners.
- Home‑Cooked Options require a balanced recipe formulated by a veterinary nutritionist to avoid deficiencies.
11. Zoonotic Risks (or Lack Thereof)
Heart murmurs themselves are non‑infectious and pose no direct zoonotic threat. However, certain underlying infectious causes of cardiac disease can be zoonotic:
| Infectious Agent | Cardiac Manifestation | Zoonotic Potential |
|---|---|---|
| Bartonella henselae (cat‑scratch disease) | Endocarditis | Can infect humans (cat‑scratch fever) but rare cardiac involvement. |
| Coxiella burnetii (Q fever) | Rare endocarditis | Zoonotic; transmitted via aerosolized birth fluids. |
| Leptospira spp. | Myocarditis & arrhythmias | Zoonotic; transmitted through contaminated water/urine. |
| Rickettsia spp. | Myocarditis (very rare) | Zoonotic; tick‑borne. |
Practical Advice for Owners
- Maintain good hygiene (hand washing after handling pets, especially after cleaning urine or feces).
- Keep vaccinations up‑to‑date (e.g., leptospirosis where endemic).
- Use tick control and preventive parasite programs.
- If a dog is diagnosed with bacterial endocarditis, isolate the animal during the acute treatment phase and follow veterinarian‑directed infection control measures.
Overall, the cardiac murmur itself does not transmit to humans, and the risk is limited to the underlying infectious condition, which is uncommon.
12. Take‑Home Summary
- Heart murmurs are audible clues that signal turbulent blood flow; they may be innocent or indicative of serious heart disease.
- Myxomatous mitral valve disease dominates in small breeds, while dilated cardiomyopathy and congenital outflow tract defects are more common in larger or specific breeds.
- Early detection via routine auscultation, especially in predisposed breeds, dramatically improves outcomes.
- Echocardiography remains the diagnostic gold standard for characterizing the lesion, grading severity, and guiding therapy.
- Medical therapy (pimobendan, ACE inhibitors, diuretics) stabilizes many dogs with MMVD; interventional procedures (PDA coil occlusion, balloon valvuloplasty) cure selected congenital defects.
- Prognosis varies: mild murmurs may never cause clinical disease, while severe, untreated lesions can be fatal within months.
- Lifestyle modifications—optimal weight, low‑salt diet, regular low‑impact exercise, and avoidance of tobacco smoke—help to slow disease progression.
- Nutrition tailored to cardiac health (low sodium, omega‑3 enrichment, antioxidants) supports myocardial function and reduces edema.
- Zoonotic concerns are minimal; only certain infectious causes of endocarditis carry a small human risk, mitigated by standard hygiene and preventive care.
By integrating vigilant screening, evidence‑based treatment, and owner education, most dogs with heart murmurs can enjoy a high quality of life and a longer, happier lifespan.
#HeartMurmurDogs, #CanineCardiology, #MMVD, #PuppyHeartHealth, #SeniorDogCare, #DogHeartDisease, #VeterinaryMedicine, #DogBreedsAtRisk, #CardiacMurmur, #DogHeartMurmur, #HeartFailureDogs, #Pimobendan, #ACEInhibitors, #LowSodiumDiet, #Omega3ForDogs, #DogNutrition, #DilatedCardiomyopathy, #PatentDuctusArteriosus, #BalloonValvuloplasty, #DogHealthTips, #DogOwnersGuide, #VetCare, #ZoonoticAwareness, #DogWellness, #HeartHealth, #CanineWellbeing, #DogLife, #PetHealth, #DogLovers, #DogMedicalInfo.

Add comment